Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study
Authors
Keywords
-
Journal
BMJ Open
Volume 4, Issue 7, Pages e005535-e005535
Publisher
BMJ
Online
2014-07-10
DOI
10.1136/bmjopen-2014-005535
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increasing value and reducing waste: addressing inaccessible research
- (2014) An-Wen Chan et al. LANCET
- Publication Bias, with a Focus on Psychiatry: Causes and Solutions
- (2013) Erick H. Turner CNS DRUGS
- Haphazard reporting of deaths in clinical trials: a review of cases of ClinicalTrials.gov records and matched publications–a cross-sectional study
- (2013) Amy Earley et al. BMJ Open
- Restoring invisible and abandoned trials: a call for people to publish the findings
- (2013) P. Doshi et al. BMJ-British Medical Journal
- Are clinical trial data shared sufficiently today? Yes
- (2013) J. Castellani BMJ-British Medical Journal
- Are clinical trial data shared sufficiently today? No
- (2013) B. Goldacre BMJ-British Medical Journal
- Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion
- (2013) M. A. Rodgers et al. BMJ-British Medical Journal
- Non-publication of large randomized clinical trials: cross sectional analysis
- (2013) C. W. Jones et al. BMJ-British Medical Journal
- Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals
- (2013) Carolina Riveros et al. PLOS MEDICINE
- Completeness of Reporting of Patient-Relevant Clinical Trial Outcomes: Comparison of Unpublished Clinical Study Reports with Publicly Available Data
- (2013) Beate Wieseler et al. PLOS MEDICINE
- The Evolution of Trial Registries and Their Use to Assess the Clinical Trial Enterprise
- (2012) Kay Dickersin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Europe's drug agency will publish clinical trial data for new products from 2014
- (2012) I. Torjesen BMJ-British Medical Journal
- The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience
- (2012) Peter Doshi et al. PLOS MEDICINE
- Promoting Transparency in Pharmaceutical Industry–Sponsored Research
- (2011) Joseph S. Ross et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Increasing off-label use of antipsychotic medications in the United States, 1995-2008
- (2011) G. C. Alexander et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- For What Diagnoses Are Psychotropic Medications Being Prescribed?
- (2010) Tami L. Mark CNS DRUGS
- The Benefits and Savings from Publicly Funded Clinical Trials of Prescription Drugs
- (2008) Dean Baker INTERNATIONAL JOURNAL OF HEALTH SERVICES
- Industry-Sponsored Clinical Research
- (2008) Marcia Angell JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
- (2008) Erick H. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started